Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and diseases. 复合年增长率为 4.6% 从 2021 到 2027, the global biobanking market is projected to reach worth of USD 70,177 到 2027 年底将达到 100 万, 根据 Gen Consulting 公司的一份新报告.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global biobanking market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the biobanking industry.

The biobanking market is segmented on the basis of sample type, 所有权, 应用, 和地区. The biobanking market is segmented as below:

By sample type:
– biofluids
– human tissues
– stem cells
– DNA/RNA
– 其他的

By ownership:
– national & regional agencies
– 大学
– non-profit organization
– private organization

按申请:
– 研究
– therapeutics

按地区:
– 地区
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The report also provides a detailed analysis of several leading biobanking market vendors that include All of Us, Biobank Graz, Biobank VAST, Danish National Biobank, Kaiser Permanente Research Bank, National Liver Disease Biobank, The Cancer Human Biobank (caHUB), UK Biobank Limited, Uppsala Biobank, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2017 到 2027 考虑到 2020 为基准年.

报告范围
– To analyze and forecast the market size of the global biobanking market.
– To classify and forecast the global biobanking market based on sample type, 所有权, 应用, 和地区.
– To identify drivers and challenges for the global biobanking market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global biobanking market.
– To identify and analyze the profile of leading players operating in the global biobanking market.

为什么选择这份报告
– Gain a reliable outlook of the global biobanking market forecasts from 2021 到 2027 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.